Frankfurt
22.07.26 | 08:02
4,180 Euro
+2,96 % +0,120
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,200 | 4,300 | 08:39 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Exagen Inc.: Exagen to Announce Second Quarter Financial Results on August 4, 2026 | 1 | GlobeNewswire (USA) | ||
| 09.06. | EXAGEN INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.06. | Exagen Inc.: Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus | 1 | GlobeNewswire (USA) | ||
| 12.05. | BTIG senkt Kursziel für Exagen auf 8 US-Dollar, bestätigt aber 'Buy'-Rating | 1 | Investing.com Deutsch | ||
| 12.05. | Exagen stock price target lowered to $8 by BTIG on valuation | 1 | Investing.com | ||
| 12.05. | Exagen reaffirms $70M-$73M 2026 revenue guidance as it targets $600-$650 ASP over time | 1 | Seeking Alpha | ||
| EXAGEN Aktie jetzt für 0€ handeln | |||||
| 11.05. | Exagen Inc. (XGN) Reports Q1 Loss, Beats Revenue Estimates | 1 | Zacks | ||
| 11.05. | Exagen: EPS übertrifft Schätzungen um 0,05 $ - Umsatz besser als erwartet | 1 | Investing.com Deutsch | ||
| 11.05. | EXAGEN INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.05. | Exagen beats top-line and bottom-line estimates; reaffirms FY26 outlook | 1 | Seeking Alpha | ||
| 11.05. | Exagen Inc. Reports First Quarter 2026 Results | 245 | GlobeNewswire (Europe) | CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026... ► Artikel lesen | |
| 11.05. | EXAGEN INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.04. | Does Exagen (XGN)'s 200%+ Upside Potential Make It One of the Best Penny Stocks Set to Explode? | 3 | Insider Monkey | ||
| 10.03. | Exagen outlines $70M-$73M 2026 revenue target while expanding sales force and innovation cadence | 1 | Seeking Alpha | ||
| 10.03. | BTIG cuts Exagen stock price target to $9 on lower revenue outlook | 1 | Investing.com | ||
| 10.03. | Exagen stock maintains Outperform rating at William Blair | 3 | Investing.com | ||
| 10.03. | Exagen: William Blair hält an Outperform-Einstufung fest | 2 | Investing.com Deutsch | ||
| 10.03. | Exagen verfehlt Gewinn- und Umsatzprognose für Q4 2025 - Aktie unter Druck | 3 | Investing.com Deutsch | ||
| 10.03. | EXAGEN INC. - 10-K, Annual Report | 2 | SEC Filings | ||
| 10.03. | Exagen GAAP EPS of -$0.20 misses by $0.01, revenue of $16.63M beats by $0.06M | 2 | Seeking Alpha |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HENRY SCHEIN | 75,50 | 0,00 % | Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report? | ||
| CO-DIAGNOSTICS | 2,330 | -1,27 % | Co-Diagnostics Appoints Wes Lindsey, PhD, MBA as Chief Scientific Officer | SALT LAKE CITY, July 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented... ► Artikel lesen | |
| AMBU | 9,545 | +2,03 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen | |
| CYTOSORBENTS | 0,358 | +2,87 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,940 | -6,19 % | Clover Health reveals data breach in SEC filing | ||
| FULGENT GENETICS | 17,300 | -0,57 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| PERIMETER MEDICAL IMAGING AI | 0,179 | +1,70 % | Perimeter Medical Imaging AI Inc.: Perimeter Announces First Quarter 2026 Financial Results | Conference call/webcast today at 5:00 pm ET
TORONTO and DALLAS, May 28, 2026 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTCQX: PYNKF) ("Perimeter"... ► Artikel lesen | |
| ICON | 145,05 | -1,06 % | ICON plc: ICON Reports First Quarter 2026 Results | Highlights
Quarter one revenue of $2,034.0 million, an increase of 0.9% on quarter one 2025.
Quarter one adjusted EBITDA of $317.7 million or 15.6% of revenue.
GAAP net income... ► Artikel lesen | |
| IMAGIN MEDICAL | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2026.ISIN NameCA2985962067 EUREKA... ► Artikel lesen | |
| MEMPHASYS | 0,003 | -14,29 % | MEMPHASYS LIMITED: Proposed issue of securities - MEM | ||
| ESTABLISHMENT LABS | 82,44 | -1,65 % | ESTABLISHMENT LABS HOLDINGS INC. - 8-K, Current Report | ||
| EMBECTA | 2,941 | -0,64 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| CHECK-CAP | 0,825 | -7,82 % | Humanoid Global meldet Fortschritte von MBody AI bei der kommerziellen Expansion und dem geplanten Unternehmenszusammenschluss mit Check-Cap | Vancouver, BC / 14. Juli 2026 / IRW-Press / Humanoid Global
Holdings Corp. ("Humanoid Global" oder das "Unternehmen")
(CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), ein börsennotierter
Investment-Emittent... ► Artikel lesen | |
| ELECTROCORE | 5,400 | +5,88 % | electroCore, Inc.: New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation | ||
| CATHETER PRECISION | 0,480 | -2,89 % | Catheter Precision, Inc.: Flyte Partners with Blade to Expand Vision Jet Distribution |
Das Unternehmen EXAGEN INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,120 (+2,96 %) liegt der Kurs bei 4,180 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXAGEN INC finden Sie auf Wallstreet Online.